Highlights Sanofi Nasdaq

Equities

SNY

US80105N1054

Market Closed - Nasdaq Other stock markets 01:30:00 04/06/2024 am IST			5-day change	1st Jan Change
49.25 ^USD	+0.45%		+1.46%	-0.97%

06:32am	Sanofi's Blood Cancer Drug Sarclisa Meets Primary, Secondary Endpoints in Phase 3 Trial	MT
03/06	DHL Strikes Logistics Partnership with Sanofi	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sanofi's Blood Cancer Drug Sarclisa Meets Primary, Secondary Endpoints in Phase 3 Trial	10:02am	MT
DHL Strikes Logistics Partnership with Sanofi	03/06	MT
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to proceed	03/06	RE
Sanofi Enlists Banks for EUR20 Billion Consumer Health Spinoff, IPO	03/06	MT
GSK Plans Appeal Against US Judge's Ruling on Jury Trials for Zantac Cases	03/06	MT
Sanofi Moving Ahead With EUR20Bln Consumer Healthcare Spinoff, FT Reports	03/06	DJ
Sanofi Enlists Banks for EUR20 Billion Consumer Health Spinoff, IPO	03/06	MT
Delaware judge lets more than 70,000 Zantac lawsuits go forward	02/06	RE
CAC40: remains at equilibrium despite sharp decline in Nasdaq and S&P	31/05	CF
CAC40: May ends with no trend and a zero score	31/05	CF
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review	31/05	RE
Sanofi: launch of employee share ownership plan 2024	31/05	CF
Regeneron Pharmaceuticals, Sanofi Say Dupixent FDA Application Decision Delayed by 3 Months	31/05	MT
Regeneron Pharmaceuticals, Inc and Sanofi Announce Dupixent® Recommends for EU Approval by the CHMP to Treat Patients with COPD	31/05	CI
Regeneron Pharmaceuticals, Inc and Sanofi Announces Update on FDA Priority Review of Dupixent® for the Treatment of COPD Patients with Type 2 Inflammation	31/05	CI
CAC40: regains some altitude, Airbus in support	30/05	CF
Sanofi Closes Purchase of US Biotech Company Inhibrx	30/05	MT
Sanofi: acquisition of Inhibrx finalized	30/05	CF
Sanofi Opens New Advanced Vaccines Facility, Strengthening Its Commitment to Biomanufacturing in Canada	30/05	CI
Sanofi Adds over ?1 Billion for Biomanufacturing to ?2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty	28/05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 05:28 pm IST

Sanofi Sees Trend for Years of Steady Growth: CFO

February 04, 2023 at 02:26 am IST